CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Tiziana Life Sciences completes patient visits in Phase 2a MS drug trial

Phase 2Neutral
AI Analysis

Summary

Tiziana Life Sciences has completed patient visits in a Phase 2a trial for an MS drug candidate. The completion of patient visits represents a milestone in the trial's progression.

Clinical Trial Data

Phase

2a

Importance:4/10
Sentiment:
0.00
Phase 2aMultiple SclerosisClinical TrialPatient Visit Completion
Related Companies

Read the original article

Published by yahoo_finance on September 21, 2026 1:28 PM

Read Original